Debra Ritzwoller to Aged
This is a "connection" page, showing publications Debra Ritzwoller has written about Aged.
Connection Strength
1.765
-
Patterns of recurrence among adults diagnosed with screen-detected lung cancer. Cancer Epidemiol. 2025 Apr; 95:102777.
Score: 0.113
-
Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium. JCO Clin Cancer Inform. 2023 Sep; 7:e2300063.
Score: 0.102
-
Individuals Eligible for Lung Cancer Screening Less Likely to Receive Screening When Enrolled in Health Plans With Deductibles. Med Care. 2023 Oct 01; 61(10):665-673.
Score: 0.102
-
Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. JAMA Netw Open. 2021 10 01; 4(10):e2128176.
Score: 0.090
-
Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML. J Natl Compr Canc Netw. 2019 10 01; 17(10):1166-1172.
Score: 0.078
-
Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study. Cancer Med. 2019 08; 8(9):4508-4516.
Score: 0.077
-
Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease. J Oncol Pract. 2019 07; 15(7):e616-e627.
Score: 0.076
-
Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis. Health Serv Res. 2018 12; 53(6):5106-5128.
Score: 0.072
-
Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm. J Natl Cancer Inst. 2018 03 01; 110(3):273-281.
Score: 0.070
-
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2017 12; 55(12):e88-e98.
Score: 0.069
-
Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol. 2017 08; 49:186-194.
Score: 0.067
-
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):189-197.e3.
Score: 0.063
-
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
Score: 0.058
-
Advanced imaging among health maintenance organization enrollees with cancer. J Oncol Pract. 2014 Jul; 10(4):231-8.
Score: 0.054
-
Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience. J Thorac Oncol. 2014 May; 9(5):692-701.
Score: 0.054
-
Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
Score: 0.052
-
Economic analyses of the Be Fit Be Well program: a weight loss program for community health centers. J Gen Intern Med. 2013 Dec; 28(12):1581-8.
Score: 0.050
-
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
Score: 0.048
-
Outcomes of minimal and moderate support versions of an internet-based diabetes self-management support program. J Gen Intern Med. 2010 Dec; 25(12):1315-22.
Score: 0.041
-
Recruitment to a randomized web-based nutritional intervention trial: characteristics of participants compared to non-participants. J Med Internet Res. 2009 Aug 26; 11(3):e38.
Score: 0.039
-
Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin. 2009 Jun; 25(6):1319-28.
Score: 0.038
-
Costing behavioral interventions: a practical guide to enhance translation. Ann Behav Med. 2009 Apr; 37(2):218-27.
Score: 0.038
-
The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord. 2006 Sep 18; 7:72.
Score: 0.032
-
Adherence to Annual Lung Cancer Screening and Rates of Cancer Diagnosis. JAMA Netw Open. 2025 Mar 03; 8(3):e250942.
Score: 0.028
-
Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med. 2005 Mar; 7(3):191-7.
Score: 0.028
-
Changes in use of opioid therapy after colon cancer diagnosis: a population-based study. Cancer Causes Control. 2019 Dec; 30(12):1341-1350.
Score: 0.020
-
Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103.
Score: 0.018
-
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
Score: 0.018
-
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
Score: 0.017
-
Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System. J Oncol Pract. 2017 05; 13(5):e441-e450.
Score: 0.016
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.016
-
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73.
Score: 0.014
-
Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015 Jun; 9(2):201-7.
Score: 0.014
-
Positron emission tomography and stage migration in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2014 Jul; 140(7):654-61.
Score: 0.014
-
When does an episode of care for cancer begin? Med Care. 2013 Apr; 51(4):324-9.
Score: 0.012
-
The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system. J Natl Cancer Inst Monogr. 2013; 2013(46):99-105.
Score: 0.012
-
A standardized relative resource cost model for medical care: application to cancer control programs. J Natl Cancer Inst Monogr. 2013; 2013(46):106-16.
Score: 0.012
-
Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012 Nov 15; 118(22):5644-51.
Score: 0.012
-
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
Score: 0.012
-
Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research. Med Care. 2009 Oct; 47(10):1091-7.
Score: 0.010
-
Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med. 2005 Aug; 29(2):77-84.
Score: 0.007
-
Extending health maintenance organization insurance to the uninsured. A controlled measure of health care utilization. JAMA. 1997 Apr 02; 277(13):1067-72.
Score: 0.004